Headline
The latest stories from AHA Today.
The Federal Reserve Board announced it will seek public comments on a proposal to expand its Main Street Lending Program to provide access to credit for nonprofit organizations, including hospitals, a move advocated for by the AHA.
AHA submitted comments on the Centers for Medicare & Medicaid Services’ proposed rule on the inpatient rehabilitation facility prospective payment system for fiscal year 2021.
The U.S. Supreme Court held that the definition of sex under Title VII, the federal law prohibiting discrimination in the workplace, includes sexual orientation and gender identity.
Nearly one in four workers, about 37.7 million, are at higher risk for serious illness if infected by COVID-19 due to age or underlying health conditions, according to a study released by the Kaiser Family Foundation.
The Food and Drug Administration last week issued an emergency use authorization for Cue Health Inc.’s new SARS-CoV-2 nasal swab test in patient care settings.
The Centers for Disease Control and Prevention has consolidated its recommendations for COVID-19 testing, which it will update as additional information becomes available.
The Food and Drug Administration said it no longer authorizes the use of hydroxychloroquine or chloroquine as an effective treatment of COVID-19.
In a letter to the editor, AHA President and CEO Rick Pollack notes, “Even before the Covid-19 pandemic, the financial state of many hospitals was very fragile, with one of every four hospitals in America operating in the red.
AHA identified legislative and regulatory actions needed to maintain or extend telehealth flexibilities implemented during the COVID-19 public health emergency.
The Department of Health and Human Services announced that it is planning an additional distribution of funds to hospitals that have been particularly affected by the increased burden of caring for those with COVID-19.